I found an interesting article in the "Wall street Journal" about shift of the pharmaceutical marketing to digital tool. On one hand companies developed interesting "point touch" for physicians, on the other hand, for new launches (not too many lately unfortunately) Boehringer Ingelheim confessed there is no replacement to face to face meetings and the personal trust between a physician and a sales representative.
My personal view is that new technologies can add to the marketing armamentarium, but the traditional detailing is no doubt not replaceable.
So, what is the balance and optimum?
No doubt a good sales rep is a valuable asset.
New technologies will take more time to penetrate and become really a day to day effective and useful tool.
No comments:
Post a Comment